Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells
- PMID: 3574293
Adenosine dialdehyde: a potent inhibitor of vaccinia virus multiplication in mouse L929 cells
Abstract
Adenosine dialdehyde (2'-O-[(R)-formyl(adenin-9-yl)methyl]-(R)-glyceraldehyde), formed by periodate oxidation of adenosine, is a potent inhibitor of S-adenosylhomocysteine hydrolase (EC 3.3.1.1.) in mouse L929 cells. Consequently, the dialdehyde produces an increase in intracellular levels of S-adenosylhomocysteine and subsequent inhibition of S-adenosylmethionine-dependent macromolecular methylations. In the present study we show that adenosine dialdehyde is also a potent inhibitor of vaccinia virus plaque formation in monolayer cultures of L cells. When added to the culture medium immediately following attachment of the virus, concentrations of the dialdehyde as low as 0.5 microM produce greater than 90% inhibition of plaque formation after 72 hr. The efficacy of the compound is greatest when added within 8 hr of virus attachment and gradually decreases in a time-dependent manner when added after this point. Treatment of L cells with 5 microM adenosine dialdehyde for 60 min prior to virus infection causes a transient, but virtually complete loss of S-adenosylhomocysteine hydrolase activity and subsequent 3-fold increase in the intracellular S-adenosylhomocysteine/S-adenosylmethionine ratio. Continuous exposure of infected cells to the dialdehyde results in prolonged inhibition of S-adenosylhomocysteine hydrolase accompanied by a 10-fold increase in the S-adenosylhomocysteine/S-adenosylmethionine ratio. Associated with these changes in the dialdehyde-treated, infected cells are an inhibition of early virus-specific protein synthesis and a 13% decrease in methylation of the cytoplasmic poly A+-mRNA. The antiviral action of this compound thus appears to be related to a decrease in viral mRNA methylation (e.g., the 5'-terminal cap structure) which results in suppressed translation of viral proteins essential for virus replication.
Similar articles
-
Effects of adenosine dialdehyde on S-adenosylhomocysteine hydrolase and S-adenosylmethionine-dependent transmethylations in mouse L929 cells.Mol Pharmacol. 1984 May;25(3):418-24. Mol Pharmacol. 1984. PMID: 6727864
-
Elucidation of the mechanism by which homocysteine potentiates the anti-vaccinia virus effects of the S-adenosylhomocysteine hydrolase inhibitor 9-(trans-2',trans-3'-dihydroxycyclopent-4'-enyl)-adenine.Mol Pharmacol. 1989 Sep;36(3):490-6. Mol Pharmacol. 1989. PMID: 2779528
-
Effects of 4'-modified analogs of aristeromycin on the metabolism of S-adenosyl-L-homocysteine in murine L929 cells.Mol Pharmacol. 1993 Jun;43(6):989-97. Mol Pharmacol. 1993. PMID: 8316227
-
S-Adenosylhomocysteine hydrolase as a target for intracellular adenosine action.Trends Pharmacol Sci. 2004 Jun;25(6):294-7. doi: 10.1016/j.tips.2004.04.004. Trends Pharmacol Sci. 2004. PMID: 15165742 Review.
-
Messenger RNA methylation, translation and degradation in extracts of interferon-treated cells.Tex Rep Biol Med. 1977;35:221-9. Tex Rep Biol Med. 1977. PMID: 358450 Review.
Cited by
-
Relationship between intracellular concentration of S-adenosylhomocysteine and inhibition of vaccinia virus replication and inhibition of murine L-929 cell growth.Antimicrob Agents Chemother. 1989 Jun;33(6):828-34. doi: 10.1128/AAC.33.6.828. Antimicrob Agents Chemother. 1989. PMID: 2764532 Free PMC article.
-
9-(trans-2',trans-3'-Dihydroxycyclopent-4'-enyl)-adenine and -3-deazaadenine: analogs of neplanocin A which retain potent antiviral activity but exhibit reduced cytotoxicity.Antimicrob Agents Chemother. 1987 Nov;31(11):1849-51. doi: 10.1128/AAC.31.11.1849. Antimicrob Agents Chemother. 1987. PMID: 2449123 Free PMC article.
-
Clinical Performance of Paraoxonase-1-Related Variables and Novel Markers of Inflammation in Coronavirus Disease-19. A Machine Learning Approach.Antioxidants (Basel). 2021 Jun 21;10(6):991. doi: 10.3390/antiox10060991. Antioxidants (Basel). 2021. PMID: 34205807 Free PMC article.
-
In Silico Discovery of Candidate Drugs against Covid-19.Viruses. 2020 Apr 6;12(4):404. doi: 10.3390/v12040404. Viruses. 2020. PMID: 32268515 Free PMC article.
-
On the Role of Paraoxonase-1 and Chemokine Ligand 2 (C-C motif) in Metabolic Alterations Linked to Inflammation and Disease. A 2021 Update.Biomolecules. 2021 Jul 1;11(7):971. doi: 10.3390/biom11070971. Biomolecules. 2021. PMID: 34356595 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous